NeuroSense Therapeutics Ltd. Increase Decrease Through Exercise Of Warrants Equity
NeuroSense Therapeutics Ltd. (NRSN) reported Increase Decrease Through Exercise Of Warrants Equity of $4.31 million for the 12-month period ending 2022-12-31, per its 6-K filed 2023-08-16.
Discontinued › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2024-04-04
| Period end | Increase Decrease Through Exercise Of Warrants Equity 1 month | Increase Decrease Through Exercise Of Warrants Equity 6 month | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|---|---|
| 2022-12-31 | $4.31M 6-K · filed 2023-08-16 | ||
| 2022-06-30 | $4.31M 6-K · filed 2023-08-16 | ||
| 2022-03-31 | $645.00K 20-F · filed 2023-03-22 | ||
| 2021-12-31 | $1.31M 20-F · filed 2024-04-04 |